Vaccines protect against infection from Omicron subvariant — but not for long

Indonesia Berita Berita

Vaccines protect against infection from Omicron subvariant — but not for long
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 Nature
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 68%

Two doses of COVID vaccine cut the risk of infection and mild illness from the rising BA.2 subvariant, although protection wanes quickly.

collected in the United Kingdom reveal a similar trend: vaccine effectiveness against symptomatic COVID-19 is less than 20% for both subvariants 25 weeks or more after a second dose, but rises to roughly 70% 2–4 weeks after a third dose.severe disease

This analysis showed that protection against severe disease remained at 68% or higher for at least 7 months, even in people who had only received two vaccine doses, and shot up to over 80% after a booster dose. Abu-Raddad says that because 70-80% of the pooled cases were BA.2, he suspects that vaccines still offer a high level of protection against severe disease in the face of surging BA.2 levels.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

Nature /  🏆 64. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Vaccines protect against infection from Omicron subvariant — but not for longTwo doses of COVID vaccine cut the risk of infection and mild illness from the rising BA.2 subvariant, although protection wanes quickly.
Baca lebih lajut »

Alaska on Friday reports 510 cases of COVID-19 over two daysAlaska on Friday reports 510 cases of COVID-19 over two daysAbout a third of the most recently sequenced coronaviruses in Alaska were the BA.2 “stealth” omicron subvariant
Baca lebih lajut »

Moderna, Pfizer push for 4th doses despite only minor benefits in studyModerna, Pfizer push for 4th doses despite only minor benefits in studyA study found Israeli healthcare workers given fourth coronavirus vaccine shot at the height of Omicron were only marginally more protected against reinfection.
Baca lebih lajut »

Omicron BA.2 subvariant becoming dominant, representing potential riskOmicron BA.2 subvariant becoming dominant, representing potential riskICYMI: Omicron BA.2 subvariant becoming dominant, representing potential risk
Baca lebih lajut »

NPR Cookie Consent and Choices
Baca lebih lajut »

You May Already Be Protected From the New COVID Variant — Best LifeYou May Already Be Protected From the New COVID Variant — Best LifeResearch shows that vaccinated people who recently had breakthrough Omicron infections may be protected from the new BA.2 COVID variant.
Baca lebih lajut »



Render Time: 2025-03-10 10:13:01